6:57 AM
 | 
Aug 31, 2018
 |  BC Extra  |  Financial News

Qiming, Hillhouse lead Jacobio's $55M series C

Cancer company Beijing Jacobio Pharmaceutical Co. Ltd. (Beijing, China) raised $55 million in a series C round led by Qiming Venture Capital and Hillhouse Capital. Prudence Investment Management also participated.

Jacobio's lead candidate...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >